Sudeep Pharma Ltd Appoints Sharp & Tannan Associate as Internal Auditor for FY 2026-27 and Reports Q3 and Nine Months Financial Results

Sudeep Pharma Ltd has appointed Sharp & Tannan Associate as the Internal Auditor for the financial year 2026-27. The appointment was made at the Board of Directors meeting held on 6th February 2026. The firm, established in 1934, is known for its risk-based auditing and value-added approach to business processes. Sudeep Pharma Ltd also released its unaudited standalone and consolidated financial results for the third quarter and nine months ended on 31st December 2025.